Quick Answer
CHINA PHARMA HOLDINGS, INC. reported Stockholders Equity of $7.75 million for fiscal year 2024.
CHINA PHARMA HOLDINGS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | $7.75M | +3.9% |
| 2023 | $7.45M | +73.8% |
| 2022 | $4.29M | -28.7% |
| 2021 | $6.02M | -24.8% |
| 2020 | $8.00M | -13.3% |
| 2019 | $9.24M | -69.4% |
| 2018 | $30.20M | -29.9% |
| 2017 | $43.07M | -26.9% |
| 2016 | $58.91M | -18.9% |
| 2015 | $72.64M | -21.7% |
| 2014 | $92.74M | -30.2% |
| 2013 | $132.94M | -10.5% |
| 2012 | $148.52M | +4.2% |
| 2011 | $142.48M | +20.8% |
| 2010 | $117.94M | +34.2% |
| 2009 | $87.87M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.31M | +27.4% | +28.7% |
| June 30, 2025 | $6.46M | -12.8% | -7.3% |
| March 31, 2025 | $6.97M | -15.9% | -10.0% |
| December 31, 2024 | $7.75M | +3.9% | +18.7% |
| September 30, 2024 | $6.53M | +6.8% | -11.9% |
| June 30, 2024 | $7.41M | +70.2% | -10.7% |
| March 31, 2024 | $8.29M | +77.6% | +11.2% |
| December 31, 2023 | $7.45M | +73.8% | +22.0% |
- CHINA PHARMA HOLDINGS, INC. showed an increase of +3.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2024 period, CHINA PHARMA HOLDINGS, INC.’s stockholders equity has declined by 91.2% (from $87.87 million to $7.75 million).
- The most recent figure is from CHINA PHARMA HOLDINGS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: